ENDRA Life Sciences Inc.
NDRA· Nasdaq
NDRAENDRA Life Sciences Inc.
Filed Nov 5, 2018 · 10-Q · 36 days after period end · 0001654954-18-012009
| Metric | Q3 2018 | Q3 2017 | Q3 2016 |
|---|---|---|---|
| Revenue | $0.00 | $287.00K | $0.00 |
| Net Income | -$2.76M | -$908.91K | -$977.90K |
| EPS Diluted | -$0.70 | -$0.23 | -$1.35 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ENDRA Life Sciences Inc. · CIK 1681682 · Engraved from SEC EDGAR
ended Sep 30, 2018 · filed Nov 5, 2018 · 36 d after period end
